We are monitoring the impact of COVID-19 on Europe Vaccine Adjuvant Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 625
Share on
Share on

Europe Vaccine Adjuvant Market Research Report – Segmented By Type, By Route Of Administration, By Mechanism Of Action, By Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, Forecast (2019-2024)

Pulished: August, 2019
ID: 625
Pages: 145

The size of the European Vaccine Adjuvant Market was worth USD 139.07 million in 2019 and estimated to be growing at a CAGR of 10.55%, to reach USD 229.63 million by 2024. Europe is the second-largest vaccine adjuvant market globally.

Vaccine adjuvant is an agent that helps to produce more antibodies and create a longer-lasting immunity. Europe vaccine market is driven by increasing patients of infectious diseases as well as cancer in the region. Recently, the coronavirus outbreak has helped the growth of the European vaccine adjuvant market as it is an infectious disease. Also, the developed technology of Germany and Italy is helping the addition of innovative vaccine adjuvant for the use of flu diseases. High prevalence of HIV and Coronavirus disease is driving the growth of Europe vaccine adjuvant market. The government and NGOs have funding to clinical trials for the new adjuvant vaccine discovery that can boost the immunity in this pandemic situation.

However, side effects and high costs of treatment associated with the vaccine adjuvants are hampering the growth of the market to some extent. The advanced and recent molecular antigen technologies will need of highly competent and powerful adjuvant vaccine for the immunization is a big challenge for the adjuvant vaccine market. As per the European authority, the adjuvant cannot get approval without vaccine and lacks universities appear due to safety its hurdle for this market in Europe.

This research report segmented and sub-segmented into the following categories:

  • By Type: Aluminium Salts, Tensoactive Adjuvants, Adjuvant Emulsions, Bacteria Derived Adjuvants, Liposome Adjuvants and Carbohydrate Adjuvants.
  • By Route of Administration: Oral, Intradermal, Subcutaneous, Intranasal and Intramuscular.
  • By Mechanism of Action: Immuno Stimulants, Carriers and Vehicle Adjuvants
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe.

Regionally, Germany and U.K are expected to experience robust growth in the forecast period due to increasing awareness in the region.

Italy has created tremendous demand for the newly developed adjuvant vaccine in the market due to the high number of Coronavirus patients which are affected in this country. Government has taken the initiative to boost the immunity of patients and Developed healthcare are factors helps to the growth of the vaccine adjuvants market in Italy. High prevalence of Influenza is more in geriatric patients, and more than 10% aged population in Italy are factors driving the growth of the market.

Germany vaccine adjuvant market is expected to grow at a robust CAGR during the forecast period due to rising geriatric population and swine flu patients. In 2019, the department of vaccinology and microbiology Germany had come up with new development of adjuvant vaccine combination with the enhanced immune response for particular antigen and antibodies to reduce the limitation of vaccine adjuvant in the market.

UK researcher has to work on this COVID-19 pandemic to launch new adjuvant vaccine which can generate the strongest, capable and most durable immune response combat SARS-COV-2 virus. The presence of prominent players in the UK for the development of vaccine adjuvant that helps to boost the UK vaccine adjuvant market.

Currently, the high prevalence of hepatitis B, influenza, and more demands for the aluminium vaccine adjuvant in France is fuelling the growth of the market.

Key players operating in Europe Vaccine Adjuvant Market profiled in this report are MPV Technologies, Avanti Polar Lipids, Novavax Inc. Brenntag Biosector, SEPPIC, Agenus, Inc., Invivogen, SPI Pharma, Inc., CSL Limited and OZ Biosciences.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Type                        

                                5.1.1 Aluminium Salts    

                                5.1.2 Tensoactive Adjuvants      

                                5.1.3 Adjuvant Emulsions            

                                5.1.4 Bacteria derived Adjuvants              

                                5.1.5 Liposome Adjuvants           

                                5.1.6 Carbohydrate Adjuvants   

                5.2 By Route of Administration                 

                                5.2.1 Oral            

                                5.2.2 Intradermal            

                                5.2.3 Subcutaneous       

                                5.2.4 Intranasal                

                                5.2.5 Intramuscular        

                5.3 By Mechanism of Action                       

                                5.3.1 Immuno Stimulants             

                                5.3.2 Carriers     

                                5.3.3 Vehicle Adjuvants

6. Geographical Analysis                                              

                                6.1 Introduction               

                                6.2 U.K 

                                6.3 Spain             

                                6.4 Germany     

                                6.5 Italy               

                                6.6 France          

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 MPV Technologies                  

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Avanti Polar Lipids                   

                8.3 Novavax Inc.                              

                8.4 Brenntag Biosector                 

                8.5 SEPPIC                          

                8.6 Agenus, Inc.                               

                8.7 Invivogen                    

                8.8 SPI Pharma Inc.                         

                8.9 CSL Limited                 

                8.10 OZ Biosciences                        

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Vaccine Adjuvant Market By Region, From 2019-2024 (USD Million)
  2. Europe Vaccine Adjuvant Market By Type, From 2019-2024 (USD Million)
  3. Europe Aluminium Salts Market By Region, From 2019-2024 (USD Million)
  4. Europe Tensoactive Adjuvants Market By Region, From 2019-2024 (USD Million)
  5. Europe Adjuvant Emulsions Market By Region, From 2019-2024 (USD Million)
  6. Europe Bacteria derived Adjuvants Market By Region, From 2019-2024 (USD Million)
  7. Europe Liposome Adjuvants Market By Region, From 2019-2024 (USD Million)
  8. Europe Carbohydrate Adjuvants Market By Region, From 2019-2024 (USD Million)
  9. Europe Vaccine Adjuvant Market By Route of Administration , From 2019-2024 (USD Million)
  10. Europe Oral Market By Region, From 2019-2024 (USD Million)
  11. Europe Intradermal Market By Region, From 2019-2024 (USD Million)
  12. Europe Subcutaneous Market By Region, From 2019-2024 (USD Million)
  13. Europe Intranasal Market By Region, From 2019-2024 (USD Million)
  14. Europe Intramuscular Market By Region, From 2019-2024 (USD Million)
  15. Europe Vaccine Adjuvant Market By Mechanism of Action, From 2019-2024 (USD Million)
  16. Europe Immuno Stimulants Market By Region, From 2019-2024 (USD Million)
  17. Europe Carriers Market By Region, From 2019-2024 (USD Million)
  18. Europe Vehicle Adjuvants Market By Region, From 2019-2024 (USD Million)
  19. U.K Vaccine Adjuvant Market By Type, From 2019-2024 (USD Million)
  20. U.K Vaccine Adjuvant Market By Route of Administration , From 2019-2024 (USD Million)
  21. U.K Vaccine Adjuvant Market By Mechanism of Action, From 2019-2024 (USD Million)
  22. Spain Vaccine Adjuvant Market By Type, From 2019-2024 (USD Million)
  23. Spain Vaccine Adjuvant Market By Route of Administration , From 2019-2024 (USD Million)
  24. Spain Vaccine Adjuvant Market By Mechanism of Action, From 2019-2024 (USD Million)
  25. Germany Vaccine Adjuvant Market By Type, From 2019-2024 (USD Million)
  26. Germany Vaccine Adjuvant Market By Route of Administration , From 2019-2024 (USD Million)
  27. Germany Vaccine Adjuvant Market By Mechanism of Action, From 2019-2024 (USD Million)
  28. Italy Vaccine Adjuvant Market By Type, From 2019-2024 (USD Million)
  29. Italy Vaccine Adjuvant Market By Route of Administration , From 2019-2024 (USD Million)
  30. Italy Vaccine Adjuvant Market By Mechanism of Action, From 2019-2024 (USD Million)
  31. France Vaccine Adjuvant Market By Type, From 2019-2024 (USD Million)
  32. France Vaccine Adjuvant Market By Route of Administration , From 2019-2024 (USD Million)
  33. France Vaccine Adjuvant Market By Mechanism of Action, From 2019-2024 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample